Penicillamine Challenge Test Methodology

Test Protocol

The penicillamine challenge test involves administering 500 mg of D-penicillamine orally at the beginning of a 24-hour urine collection and again 12 hours later, regardless of body weight, with measurement of total urinary copper excretion during this period 1, 2

The American Association for the Study of Liver Diseases recommends giving 500 mg D-penicillamine at hour 0 and 500 mg at hour 12 of the 24-hour urine collection 1
The administration route is oral 1, 2
A fixed dose of 500 mg is used regardless of patient weight (standardized only in pediatric populations) 1
Urine must be collected in copper-free glassware throughout the entire 24-hour period 1

A diagnostic cutoff of urinary copper excretion >1600 μg/24 hours (>25 μmol/24 hours) following penicillamine administration is diagnostic of Wilson's disease, as recommended by the American Association for the Study of Liver Diseases 1
A baseline 24-hour urinary copper should be measured before the challenge test, according to the American Association for the Study of Liver Diseases 1

The specificity of the test is 93-98% when compared to other liver diseases, including autoimmune hepatitis, primary sclerosing cholangitis, and acute liver failure, as reported by the European Association for the Study of the Liver 1, 2
The predictive value is 100% when the 25 μmol/24 hour cutoff is used in symptomatic patients, as stated by the American Association for the Study of Liver Diseases 1

The test has only been standardized and validated in pediatric patients under 18 years of age, according to the American Academy of Pediatrics and the European Association for the Study of the Liver 1, 3, 4, 5
The test is not recommended for diagnosis of Wilson's disease in adults due to lack of standardization, as stated by the European Association for the Study of the Liver 2

The primary indication for the test is when basal 24-hour urinary copper excretion is <100 μg/24 hours (<1.6 μmol/24 hours) in symptomatic children where Wilson's disease is still suspected, as recommended by the American Association for the Study of Liver Diseases 1
Recent data suggest that lowering the threshold for basal urinary copper excretion (without penicillamine stimulation) to 0.64 μmol/24 hours increases sensitivity and may eliminate the need for challenge testing, according to the European Association for the Study of the Liver 2

Children with autoimmune hepatitis can have elevated post-challenge urinary copper, though typically not reaching the 25 μmol/24 hour threshold, as reported by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver 1, 2
The test has lower sensitivity (12.5%) compared to other diagnostic modalities when comparing children with Wilson's disease to those with other liver diseases, as stated by the European Association for the Study of the Liver 2
Ensure proper copper-free collection containers to avoid contamination, as recommended by the American Association for the Study of Liver Diseases 1